OPPORTUNISTIC MUNICIPAL FUND INSTITUTIONAL CLASS (POMFX US) stock market data APIs
9.2589
0(0%)
as of July 11, 2025
Try our APIs with
free plan!
OPPORTUNISTIC MUNICIPAL FUND INSTITUTIONAL CLASS Financial Data Overview
Price chart is built with
Anychart
Prev. Close
9.2589
Open
9.2589
High
9.2589
Low
9.2589
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get OPPORTUNISTIC MUNICIPAL FUND INSTITUTIONAL CLASS data using free add-ons & libraries
End-of-day & Earnings data
Get OPPORTUNISTIC MUNICIPAL FUND INSTITUTIONAL CLASS Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get OPPORTUNISTIC MUNICIPAL FUND INSTITUTIONAL CLASS End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
OPPORTUNISTIC MUNICIPAL FUND INSTITUTIONAL CLASS News
New
Albireo Announces U.S. FDA Acceptance of New Drug Application for Odevixibat
- Company receives FDA Priority Review with PDUFA date set for July 20, 2021 - - Submission data for PFIC types 1, 2, 3, supporting once-daily use across a wide range of patients - - FDA has granted...
Albireo Recognizes International Alagille Syndrome Awareness Day 2021
Albireo supports the Alagille syndrome community to advocate for more education and new treatment advances for rare cholestatic liver diseases BOSTON, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma...
Albireo to Host Virtual Investor Commercial Day 2021
BOSTON, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced that it will host a vi...
Albireo to Participate in H.C. Wainwright BioConnect and LifeSci Advisors Investor Conferences
BOSTON, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced that Ron Cooper, Presi...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
